Peptide Hybrid Technology
May 10, 2012 at 10:38 | Source: Tech2.com
Apr 16, 2012 at 16:07 | Source: BizTech2.com
Jan 11, 2012 at 18:28 | Source: Tech2.com
Nov 15, 2011 at 09:14 | Source: ft.com
Oct 14, 2011 at 16:16 | Source: Reuters
Oct 14, 2011 at 11:30 | Source: Reuters
Related News »
The first product candidate utilizing the Company's novel Ii-Key Hybrid technology platform is a HER-2/neu Peptide Vaccine (AE37). This "off-the-shelf" cancer immunotherapy product candidate is easier and less costly to produce than comparable ...
May 9, 2012 at 13:24 | Source: Boston Globe
Building a Powerful Vaccine The AE37 peptide vaccine used in this study is a hybrid modified to increase its potency ... the company that licenses the vaccine technology. Based on this study, Antigen Express plans to apply for a special protocol assessment ...
May 17, 2012 at 14:33 | Source: EurekAlert
To extend its capabilities to include ultra-high resolution and accurate mass, the Velos Pro ion trap is also available in combination with industry-leading Thermo Scientific Orbitrap technology as the Orbitrap Velos Pro(TM) and Orbitrap Elite(TM ...
May 25, 2012 at 12:22 | Source: ThomasNet Industrial News Room